perimenopause and tirzepatide HRT Tirzepatide: The Key to Weight Loss After Menopause? Actual patient results under the

In the SURMOUNT-5 trial, patients treated with Tirzepatide experienced an average weight reduction of 20.2%, significantly greater than Semaglutide's 13.7%

Food-derived peptides have been investigated for their potential to modulate glucose metabolism, though clinical relevance remains uncertain

New England Journal of Medicine, 387 (3), 205216.

Theyve been helping people get real results, especially when nothing else seems to work

Beyond fat reduction, it may contribute to improved energy levels, greater metabolic flexibility, and overall well-being, supporting a healthier and more sustainable lifestyle

Step 6: Withdraw the needle and gently swirl the vial